Tuesday, December 3, 2013

Xencor Prices IPO

Monrovia-based biopharmaceuticals developer Xencor said this morning that it has priced its IPO, at $5.50 per share, and will start trading today on the NASDAQ Global Market as XNCR. Xencor sold 12,730,000 shares of its common stock in the IPO. Xencor was venture backed by MedImmune Ventures, HealthCare Ventures, and others.

---